Regulating the insulin signaling pathway to treat T2DM complicated with HF mainly aims to improve myocardial energy metabolism disorder, so as to ensure adequate heart energy and recover heart function, which is a chronic treatment. This evidence concerns the gene INS and hydrops fetalis.